Treatment for Mycobacterium avium complex lung disease
Mycobacterium avium complex (MAC) is the major pathologic nontuberculous mycobacteria causing lung disease (LD) in humans worldwide. Although the burden of MAC-LD has increased over the past two decades, treatment remains difficult because of intolerance of long-term antibiotics, lack of adherence t...
Main Authors: | Sheng-Wei Pan, Chin-Chung Shu, Jia-Yih Feng, Wei-Juin Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664620301790 |
Similar Items
-
Treatment of Mycobacterium avium Complex Pulmonary Disease
by: Yong-Soo Kwon, M.D., et al.
Published: (2019-01-01) -
Azithromycin: A promising treatment option for Mycobacterium avium complex pulmonary disease in case of intolerance to clarithromycin
by: Kengo Oshima, et al.
Published: (2021-12-01) -
A novel presentation of Mycobacterium avium complex in a recipient of a lung transplant: a case report
by: Leah Cohen, et al.
Published: (2017-08-01) -
Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation
by: Anzai, N., et al.
Published: (2022) -
Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001–2013
by: Sarah K. Brode, et al.
Published: (2019-07-01)